2026
Metabolism: Clinical and Experimental
2025 JIF 16.7肝移植後におけるGLP-1受容体作動薬とSGLT2阻害薬の転帰比較
Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial
Metabolism. 2026;185:156790.
RESEARCH PUBLICATIONS
臨床問題から出発し、研究証拠を蓄積し、国際的な学術対話に参加します。
MEMBER & COLLABORATIVE RESEARCH
原著論文、研究レター、書簡、総説、学術評論を収録しています。同一論文の参加著者はまとめて表示し、発表日順に掲載しています。
218件の独立した研究発表
84件に抄録・研究要約を掲載
合計 218 件の結果
2026
Metabolism: Clinical and Experimental
2025 JIF 16.7Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial
Metabolism. 2026;185:156790.
2026
CHEST
2025 JIF 10.2Chronic Obstructive Pulmonary Disease versus Type 2 Diabetes Mellitus: A Comparative and Additive Risk Assessment of Bone Health in a Nationwide Propensity Score-Matched Cohort.
Chest. 2026;:S0012-3692(26)06677-8.
2026
Drug Design, Development and Therapy
2025 JIF 6.1Drug Des Devel Ther. 2026;20:650968.
2026
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2024 JIF 5.22026
Clinical journal of the American Society of Nephrology : CJASN
2024 JIF 7.1Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD: Target Trial Emulation Study.
Clin J Am Soc Nephrol. 2026;.
2026
Alimentary pharmacology & therapeutics
2024 JIF 6.7Aliment Pharmacol Ther. 2026;.
2026
European journal of internal medicine
2024 JIF 6.1Eur J Intern Med. 2026;:107114.
2026
Journal of the American Heart Association
2025 JIF 6.0Maternal Autoimmune Diseases and Offspring Structural Congenital Heart Disease: A Nationwide Population-Based Cohort Study
J Am Heart Assoc. 2026;15(16):e050254.
2026
Frontiers in immunology
2024 JIF 5.9The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials.
Front Immunol. 2026;17:1867117.
2026
Drug Design, Development and Therapy
2025 JIF 6.1Comparative Risk of Psoriatic Arthritis in Type 2 Diabetes: An Emulated Target Trial of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists
Drug Des Devel Ther. 2026;20:614222.
2026
Hepatology international
2024 JIF 6.1New oral anticoagulants and hepatocellular carcinoma among patients with HBV, HCV, and alcoholic liver diseases: a nationwide cohort study.
Hepatol Int. 2026;.
2026
Epilepsia
2024 JIF 6.6Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.
Epilepsia. 2026;.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.42026
Endocrine Practice
2025 JIF 4.4Denosumab and Risk of Type 2 Diabetes Risk Among Patients With Osteoporosis: A Retrospective Cohort Study
Endocr Pract. 2026;32(9):1378–1386.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.4QJM. 2026;119(6):519-520.
2026
Diabetes, obesity & metabolism
2024 JIF 5.7GLP-1 Receptor Agonists and Risk of Age-Related Macular Degeneration in Older Adults With Obesity: A Target Trial Emulation.
Diabetes Obes Metab. 2026;28(8):6973-6984.
2026
Apoptosis : an international journal on programmed cell death
2024 JIF 8.1The GPX1-OSBPL8 axis: integrating ER ferroptosis and apoptotic signaling.
Apoptosis. 2026;31(6):145.
2026
Ophthalmology
2024 JIF 9.5Nonsteroidal Anti-inflammatory Drug Use and the Risk of Age-Related Macular Degeneration: Insights from a Multicenter Cohort Analysis.
Ophthalmology. 2026;133(9):1121-1129.
2026
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2026;14(5):1211-1212.
2026
Mayo Clinic Proceedings
2025 JIF 6.5Association of GLP-1 Receptor Agonist Use With Chronic Kidney Disease Risk in Type 2 Diabetes: Multicenter Emulated Target Trials
Mayo Clin Proc. 2026;101(6):909–919.
2026
Diabetes research and clinical practice
2024 JIF 7.4SGLT2 inhibitors and the risk of incident chronic kidney disease in type 2 diabetes: a nationwide emulated target trial in Taiwan.
Diabetes Res Clin Pract. 2026;236:113267.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.4QJM. 2026;119(4):349-350.
2026
The New England journal of medicine
2024 JIF 78.52026
International journal of biological sciences
2024 JIF 10.0Int J Biol Sci. 2026;22(8):4139-4143.
2026
Frontiers in immunology
2024 JIF 5.9Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: a population-based cohort study.
Front Immunol. 2026;17:1768882.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.4QJM. 2026;:hcag083.
2026
Frontiers in immunology
2024 JIF 5.9Dual effects of JAK vs TNF inhibitors on osteoporosis, fractures and mortality in rheumatoid arthritis: a real-world cohort study.
Front Immunol. 2026;17:1745048.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.42026
Frontiers in immunology
2024 JIF 5.9Racial disparities in ankylosing spondylitis risk following tonsillectomy: a large-scale retrospective analysis.
Front Immunol. 2026;17:1741434.
2026
Molecular cancer
2024 JIF 33.9ATP synthasome contributes to efficient energy flux in malignant breast cancer.
Mol Cancer. 2026;25(1):89.
2026
European heart journal
2024 JIF 35.62026
Diabetes care
2024 JIF 16.6Diabetes Care. 2026;49(3):e68.
2026
Theranostics
2024 JIF 13.3Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking.
Theranostics. 2026;16(9):4865-4882.
2026
Apoptosis : an international journal on programmed cell death
2024 JIF 8.1Spatially gated oxidative killing: mitoxyperilysis redefines how ROS cause lytic cell death.
Apoptosis. 2026;31(3):76.
2026
JAMA Network Open
2025 JIF 11.7GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk in Nonmalignant Uterine Diseases
JAMA Netw Open. 2026;9(2):e2558205.
2026
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2024 JIF 7.5Biomed Pharmacother. 2026;196:119103.
2026
Frontiers in immunology
2024 JIF 5.9Increased risk of inflammatory bowel disease in ankylosing spondylitis compared to psoriasis.
Front Immunol. 2026;17:1762379.
2026
Frontiers in immunology
2024 JIF 5.9Surgical removal of Waldeyer's ring and long-term risk of Sjögren's syndrome: a population-based cohort study investigating the mucosal immune link.
Front Immunol. 2026;17:1760386.
2026
QJM : monthly journal of the Association of Physicians
2024 JIF 6.4QJM. 2026;119(2):171.
2026
Diabetes research and clinical practice
2024 JIF 7.4Risk of type 2 diabetes mellitus after respiratory syncytial viral infection: A retrospective cohort study using US database.
Diabetes Res Clin Pract. 2026;233:113123.
2026
Frontiers in immunology
2024 JIF 5.9Front Immunol. 2026;17:1725709.
2025
Frontiers in immunology
2024 JIF 5.9Comparative risk of systemic autoimmune diseases in juvenile idiopathic arthritis treated with TNF-α or IL-6 inhibitors: a real-world cohort study.
Front Immunol. 2025;16:1744226.
2026
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2024 JIF 7.5Biomed Pharmacother. 2026;195:118977.
2026
Osteoarthritis and Cartilage
2025 JIF 9.2Association between denosumab use and risk of osteoarthritis among adults with osteoporosis in a real-world cohort
Osteoarthritis Cartilage. 2026;34(8):1270–1280.
2026
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
2024 JIF 5.4Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies.
Inflamm Res. 2026;75(1):15.
2026
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2026;14(1):318-319.
2025
BMC Medicine
2025 JIF 8.7Association of GLP-1 receptor agonists with herpes risks in diabetes mellitus: a target trial emulation
BMC Med. 2026;24:144.
2026
Kidney international reports
2024 JIF 5.7Sodium-Glucose Cotransporter-2 Inhibitors and Cardiorenal Events in Nonalbuminuric Kidney Disease.
Kidney Int Rep. 2026;11(3):103756.
2025
Frontiers in immunology
2024 JIF 5.9Adult-onset Still's disease presenting with aseptic meningitis: a case report.
Front Immunol. 2025;16:1660434.
2025
Nutrients
2024 JIF 5.0Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
Nutrients. 2025;17(24):3908.
2026
Diabetes, obesity & metabolism
2024 JIF 5.7Income-related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database.
Diabetes Obes Metab. 2026;28(3):1844-1853.
2026
Arthritis & Rheumatology
2025 JIF 9.9Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial
Arthritis Rheumatol. 2026;78(3):592–602.
2025
QJM : monthly journal of the Association of Physicians
2024 JIF 6.42025
Journal of the National Cancer Institute
2024 JIF 7.2J Natl Cancer Inst. 2025;117(12):2689-2690.
2025
Journal of the Royal Society of Medicine
2024 JIF 7.1SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.
J R Soc Med. 2025;118(11):347-357.
2025
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2025;13(11):3161.
2026
The American journal of medicine
2024 JIF 5.3HPV vaccination is associated with lower risk of cancers among females.
Am J Med. 2026;139(3):311-320.e12.
2025
BMC Medicine
2025 JIF 8.7Target trial emulation of DPP-4 Inhibitors in patients with T2DM for pulmonary tuberculosis: a nationwide observational data.
BMC Med. 2025;23(1):587.
2025
Frontiers in immunology
2024 JIF 5.9Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target trial emulation study.
Front Immunol. 2025;16:1673970.
2025
Journal of autoimmunity
2024 JIF 7.0Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.
J Autoimmun. 2025;157:103493.
2026
European journal of epidemiology
2024 JIF 5.9An in-depth study of the correlation between Hashimoto's thyroiditis and Sjogren's syndrome: multiple evidences from large cohorts, Mendelian randomization, and transcriptomic analysis.
Eur J Epidemiol. 2026;41(1):107-118.
2025
QJM : monthly journal of the Association of Physicians
2024 JIF 6.42025
Frontiers in immunology
2024 JIF 5.9Front Immunol. 2025;16:1651874.
2026
Journal of the American Academy of Dermatology
2024 JIF 11.82026
CNS drugs
2024 JIF 7.4Prioritizing Antihypertensive Agents in Secondary Prevention of Ischemic Stroke: A Retrospective Population-Based Study.
CNS Drugs. 2026;40(1):111-121.
2026
CHEST
2025 JIF 10.2Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial
Chest. 2026;169(2):428–439.
2025
The Journal of allergy and clinical immunology
2024 JIF 11.2J Allergy Clin Immunol. 2025;156(5):1436-1437.
2025
Diabetes, obesity & metabolism
2024 JIF 5.7Impact of SGLT2 inhibitors on the risk of age-related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
Diabetes Obes Metab. 2025;27(12):7299-7308.
2025
Frontiers in immunology
2024 JIF 5.9Increased risk of antiphospholipid syndrome in patients with psoriasis: a retrospective cohort study.
Front Immunol. 2025;16:1620768.
2025
The Journal of clinical endocrinology and metabolism
2024 JIF 5.1Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network.
J Clin Endocrinol Metab. 2025;110(10):e3366-e3375.
2025
CHEST
2025 JIF 10.22025
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2025;13(9):2534-2535.
2025
Diabetes, obesity & metabolism
2024 JIF 5.7Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes.
Diabetes Obes Metab. 2025;27(11):6403-6415.
2025
Alimentary pharmacology & therapeutics
2024 JIF 6.7Aliment Pharmacol Ther. 2025;62(7):756-757.
2025
Antioxidants (Basel, Switzerland)
2024 JIF 6.6Association Between Melatonin Use and Cataract Risk: A Target Trial Emulation Retrospective Cohort Study.
Antioxidants (Basel). 2025;14(8):1016.
2025
JAMA
2024 JIF 55.02025
Frontiers in immunology
2024 JIF 5.9Front Immunol. 2025;16:1625769.
2025
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2024 JIF 5.2Clin Exp Allergy. 2025;55(11):1165-1166.
2025
QJM : monthly journal of the Association of Physicians
2024 JIF 6.4The Association of HPV Vaccination and Risk of Immune-Mediated Diseases.
QJM. 2025;:hcaf154.
2025
Gastroenterology
2024 JIF 25.1Gastroenterology. 2025;169(6):1326.
2025
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024 JIF 5.6Low birth weight and chronic kidney disease with progression to kidney failure in children.
Nephrol Dial Transplant. 2025;40(8):1550-1558.
2026
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2026;78(1):259.
2025
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2025;77(12):1806-1807.
2025
JAMA ophthalmology
2024 JIF 9.22025
The European respiratory journal
2024 JIF 21.0Eur Respir J. 2025;66(1):2500306.
2025
Frontiers in immunology
2024 JIF 5.9The risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a real-world cohort study from 136,821 patients.
Front Immunol. 2025;16:1624223.
2025
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2024 JIF 7.32025
Journal of the National Comprehensive Cancer Network : JNCCN
2024 JIF 16.4J Natl Compr Canc Netw. 2025;23(7):e257039.
2025
JAMA Network Open
2025 JIF 11.7Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity.
JAMA Netw Open. 2025;8(7):e2521016.
2025
Diabetes/metabolism research and reviews
2024 JIF 6.0Sodium-Glucose Cotransporter 2 Inhibitors Use in Patients With Liver Cirrhosis.
Diabetes Metab Res Rev. 2025;41(5):e70070.
2025
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2025;93(4):e157-e158.
2025
Diabetes research and clinical practice
2024 JIF 7.4Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetes.
Diabetes Res Clin Pract. 2025;226:112357.
2025
EClinicalMedicine
2024 JIF 10.0Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative Network.
EClinicalMedicine. 2025;85:103319.
2026
Osteoarthritis and Cartilage
2025 JIF 9.2Osteoarthritis Cartilage. 2026;34(1):188-189.
2026
Annals of the rheumatic diseases
2024 JIF 20.6Ann Rheum Dis. 2026;85(5):e51-e52.
2025
Diabetes research and clinical practice
2024 JIF 7.4Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes.
Diabetes Res Clin Pract. 2025;226:112328.
2025
The journal of prevention of Alzheimer's disease
2024 JIF 7.8Adherence to an anti-inflammatory diet is associated with lower Alzheimer's disease mortality: A modifiable risk factor in a national cohort.
J Prev Alzheimers Dis. 2025;12(8):100221.
2025
Annals of the American Thoracic Society
2024 JIF 5.4SGLT-2 Inhibitors and the Risk of Chronic Obstructive Pulmonary Disease Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease Patients.
Ann Am Thorac Soc. 2025;22(6):846-854.
2025
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2025;13(6):1498-1499.
2025
The British journal of psychiatry : the journal of mental science
2024 JIF 7.6Br J Psychiatry. 2025;226(5):324.
2025
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2025;93(3):e115-e116.
2025
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2025;93(3):e109-e110.
2025
American journal of obstetrics and gynecology
2024 JIF 8.4Am J Obstet Gynecol. 2025;233(5):e181-e190.
2025
European heart journal
2024 JIF 35.62025
JAMA ophthalmology
2024 JIF 9.2Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes.
JAMA Ophthalmol. 2025;143(5):400-407.
2025
BMC Medicine
2025 JIF 8.7COVID- 19 vaccination reduces new-onset fibromyalgia risk in survivors.
BMC Med. 2025;23(1):255.
2025
Alimentary pharmacology & therapeutics
2024 JIF 6.7Aliment Pharmacol Ther. 2025;61(10):1721-1722.
2025
Diabetes research and clinical practice
2024 JIF 7.4Sodium-Glucose Cotransporter2 inhibitors and associated Liver-Related outcomes in diabetes patients.
Diabetes Res Clin Pract. 2025;223:112174.
2025
The American journal of medicine
2024 JIF 5.3Am J Med. 2025;138(4):e68.
2025
CHEST
2025 JIF 10.2Chest. 2025;167(4):e143-e144.
2025
International journal of biological sciences
2024 JIF 10.0Int J Biol Sci. 2025;21(6):2672-2675.
2025
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2025;93(2):e51-e52.
2026
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2026;78(3):766.
2025
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
2024 JIF 8.2The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes.
Am J Transplant. 2025;25(9):1954-1964.
2025
Gastroenterology
2024 JIF 25.1Gastroenterology. 2025;169(1):174.
2025
Diabetes research and clinical practice
2024 JIF 7.4Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: A multi-institutional TriNetX study.
Diabetes Res Clin Pract. 2025;222:112109.
2025
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2025;77(8):1108.
2025
Pharmacological research
2024 JIF 10.52025
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2025;214:107680.
2025
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2025;77(8):1113-1114.
2025
American journal of respiratory and critical care medicine
2024 JIF 19.4Am J Respir Crit Care Med. 2025;211(3):530.
2025
JAMA otolaryngology-- head & neck surgery
2024 JIF 5.6JAMA Otolaryngol Head Neck Surg. 2025;151(3):281-282.
2025
JAMA
2024 JIF 55.02025
The American journal of medicine
2024 JIF 5.32025
Age and ageing
2024 JIF 7.1Risk of new-onset dementia following COVID-19 infection: a systematic review and meta-analysis.
Age Ageing. 2025;54(3):afaf046.
2025
Journal of internal medicine
2024 JIF 9.2Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes.
J Intern Med. 2025;297(5):532-542.
2025
The American journal of gastroenterology
2024 JIF 7.6Am J Gastroenterol. 2025;120(9):2203.
2025
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2025;213:107639.
2025
American journal of respiratory and critical care medicine
2024 JIF 19.4Am J Respir Crit Care Med. 2025;211(2):291-292.
2025
QJM : monthly journal of the Association of Physicians
2024 JIF 6.42025
Anaesthesia
2024 JIF 6.92025
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
2024 JIF 6.9Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network.
BioDrugs. 2025;39(2):297-306.
2025
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2024 JIF 5.22025
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2025;92(5):e157-e158.
2025
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2025;77(7):948.
2025
BMC Medicine
2025 JIF 8.7Psoriasis increases the risk of Sjögren's syndrome: evidence from a propensity score-matched cohort study and transcriptomic analysis.
BMC Med. 2025;23(1):26.
2025
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2025;212:107601.
2025
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2024 JIF 41.92025
Journal of the American Academy of Dermatology
2024 JIF 11.8Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis.
J Am Acad Dermatol. 2025;92(5):1015-1023.
2025
Ophthalmology
2024 JIF 9.5Ophthalmology. 2025;132(4):e61.
2024
Critical care (London, England)
2024 JIF 9.3Crit Care. 2024;28(1):428.
2024
CHEST
2025 JIF 10.22024
International journal of epidemiology
2024 JIF 5.9Increased risk of subsequent antiphospholipid syndrome in patients with endometriosis.
Int J Epidemiol. 2024;54(1):dyae167.
2025
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2025;77(5):625-626.
2025
Ophthalmology
2024 JIF 9.5Ophthalmology. 2025;132(3):370-373.
2024
Critical care (London, England)
2024 JIF 9.3Crit Care. 2024;28(1):357.
2025
Gastroenterology
2024 JIF 25.1Gastroenterology. 2025;168(2):433-435.
2024
Diabetes care
2024 JIF 16.6Diabetes Care. 2024;47(11):e94-e95.
2024
CHEST
2025 JIF 10.2Chest. 2024;166(5):e172-e173.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;210:107481.
2024
NPJ vaccines
2024 JIF 6.5Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination.
NPJ Vaccines. 2024;9(1):203.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;210:107477.
2025
Gastroenterology
2024 JIF 25.1Gastroenterology. 2025;168(2):422.
2025
Gastroenterology
2024 JIF 25.1Gastroenterology. 2025;168(2):424.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;209:107473.
2025
Osteoarthritis and Cartilage
2025 JIF 9.2Osteoarthritis Cartilage. 2025;33(1):180-181.
2024
Thorax
2024 JIF 7.7Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD.
Thorax. 2024;79(11):1017-1023.
2024
Gut
2024 JIF 25.82024
European heart journal. Cardiovascular pharmacotherapy
2024 JIF 6.1Association of PCSK9 inhibitors with mortality: insights from a retrospective cohort analysis.
Eur Heart J Cardiovasc Pharmacother. 2024;10(6):505-514.
2024
Anesthesiology
2024 JIF 9.12025
The American journal of gastroenterology
2024 JIF 7.6Am J Gastroenterol. 2025;120(3):681.
2024
JAMA otolaryngology-- head & neck surgery
2024 JIF 5.6JAMA Otolaryngol Head Neck Surg. 2024;150(9):835.
2024
The New England journal of medicine
2024 JIF 78.52024
Diabetes, obesity & metabolism
2024 JIF 5.7Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan.
Diabetes Obes Metab. 2024;26(11):5399-5407.
2024
Gastroenterology
2024 JIF 25.12024
Journal of the American Academy of Dermatology
2024 JIF 11.8J Am Acad Dermatol. 2024;91(5):e137-e138.
2024
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2024;76(11):1696.
2024
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2024;12(8):2223.
2024
Journal of the American Academy of Dermatology
2024 JIF 11.8Interleukin 23 versus interleukin 12/23 inhibitors on preventing incidental psoriatic arthritis in patients with psoriasis? A real-world comparison from the TriNetX Global Collaborative Network.
J Am Acad Dermatol. 2024;91(5):889-895.
2024
Ophthalmology
2024 JIF 9.5Ophthalmology. 2024;131(10):e43.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;207:107320.
2024
JAMA internal medicine
2024 JIF 23.3JAMA Intern Med. 2024;184(7):851-852.
2024
JAMA Network Open
2025 JIF 11.7Cataract Development Among Pediatric Patients With Uveitis.
JAMA Netw Open. 2024;7(7):e2419366.
2024
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2024 JIF 20.82025
Journal of the European Academy of Dermatology and Venereology : JEADV
2024 JIF 8.0J Eur Acad Dermatol Venereol. 2025;39(2):e191-e192.
2024
European journal of internal medicine
2024 JIF 6.1Eur J Intern Med. 2024;129:143-145.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;206:107270.
2024
JAMA Network Open
2025 JIF 11.7Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus.
JAMA Netw Open. 2024;7(6):e2416578.
2024
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2024 JIF 7.3Clin Infect Dis. 2024;78(6):1775-1776.
2024
Pharmacological research
2024 JIF 10.52024
JAMA
2024 JIF 55.02024
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2024 JIF 20.8J Thorac Oncol. 2024;19(5):e6-e7.
2024
Annals of internal medicine
2024 JIF 15.2Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
Ann Intern Med. 2024;177(6):693-700.
2024
Pharmacological research
2024 JIF 10.52024
JAMA pediatrics
2024 JIF 18.0JAMA Pediatr. 2024;178(4):419.
2024
Journal of clinical anesthesia
2024 JIF 5.1General anesthesia is not associated with dementia in older adults with osteoarthritis for hip/knee replacements, a national population-based nested case-control study.
J Clin Anesth. 2024;95:111449.
2024
BMC Medicine
2025 JIF 8.7Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study.
BMC Med. 2024;22(1):117.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;202:107132.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;202:107131.
2024
Lancet (London, England)
2024 JIF 88.52024
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2024;12(3):797.
2024
JMIR medical education
2024 JIF 12.5Using ChatGPT-Like Solutions to Bridge the Communication Gap Between Patients With Rheumatoid Arthritis and Health Care Professionals.
JMIR Med Educ. 2024;10:e48989.
2024
Journal of the European Academy of Dermatology and Venereology : JEADV
2024 JIF 8.0J Eur Acad Dermatol Venereol. 2024;38(9):e825-e826.
2024
Allergy
2024 JIF 12.0Allergy. 2024;79(4):1073-1074.
2024
The Journal of clinical endocrinology and metabolism
2024 JIF 5.1Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease.
J Clin Endocrinol Metab. 2024;109(3):761-770.
2024
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2024;12(2):534.
2024
The journal of allergy and clinical immunology. In practice
2024 JIF 6.6J Allergy Clin Immunol Pract. 2024;12(2):535-536.
2024
The American journal of gastroenterology
2024 JIF 7.6Am J Gastroenterol. 2024;119(5):996.
2024
Allergy
2024 JIF 12.0Allergy. 2024;79(6):1635-1636.
2024
Allergy
2024 JIF 12.0Allergy. 2024;79(5):1396-1397.
2024
Frontiers in immunology
2024 JIF 5.9Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database.
Front Immunol. 2023;14:1302293.
2024
BMC Medicine
2025 JIF 8.7Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes.
BMC Med. 2024;22(1):8.
2024
JAMA Network Open
2025 JIF 11.7Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease.
JAMA Netw Open. 2024;7(1):e2350050.
2024
Drugs
2024 JIF 14.4Drugs. 2024;84(1):123-125.
2024
Drugs
2024 JIF 14.4Drugs. 2024;84(1):119-120.
2024
Drugs
2024 JIF 14.4Drugs. 2024;84(1):121-122.
2024
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2024 JIF 12.0Clin Gastroenterol Hepatol. 2024;22(8):1749.
2024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;199:107027.
2024
Allergy
2024 JIF 12.02024
Pharmacological research
2024 JIF 10.5Pharmacol Res. 2024;199:107026.
2024
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2024 JIF 12.02024
Brain, behavior, and immunity
2024 JIF 7.6Brain Behav Immun. 2024;115:333-334.
2024
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2024;76(3):486-487.
2024
The Lancet regional health. Western Pacific
2024 JIF 8.1Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study.
Lancet Reg Health West Pac. 2024;42:100925.
2024
Arthritis & Rheumatology
2025 JIF 9.9Arthritis Rheumatol. 2024;76(1):146.
2024
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2024 JIF 12.02024
Allergy
2024 JIF 12.0Allergy. 2024;79(2):540-541.
2024
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2024 JIF 12.0Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes.
Clin Gastroenterol Hepatol. 2024;22(6):1255-1264.e18.
一致する結果がありません。他のキーワードを試すかフィルターをクリアしてください。
JIF はジャーナルレベルの指標であり、単一論文のスコアではありません。新しく追加されたリストは 2024 JIF に従ってスクリーニングされ、既存の結果は元の指標を保持します。各エントリはその年ごとに明確にリストされています。抄録全文の中国語訳と主要な中国語抄録にはそれぞれマークが付けられています。元の内容と権限については、各記事の出典を参照してください。
| 日記 | 毎年恒例の | JIF | ソース |
|---|---|---|---|
| Age and ageing | 2024 | 7.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Alimentary pharmacology & therapeutics | 2024 | 6.7 | 2024年JIF公表概要(提供リスト) ↗ |
| Allergy | 2024 | 12.0 | 2024年JIF公表概要(提供リスト) ↗ |
| American journal of obstetrics and gynecology | 2024 | 8.4 | 2024年JIF公表概要(提供リスト) ↗ |
| American journal of respiratory and critical care medicine | 2024 | 19.4 | 2024年JIF公表概要(提供リスト) ↗ |
| American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2024 | 8.2 | 2024年JIF公表概要(提供リスト) ↗ |
| Anaesthesia | 2024 | 6.9 | 2024年JIF公表概要(提供リスト) ↗ |
| Anesthesiology | 2024 | 9.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Annals of internal medicine | 2024 | 15.2 | 2024年JIF公表概要(提供リスト) ↗ |
| Annals of the American Thoracic Society | 2024 | 5.4 | 2024年JIF公表概要(提供リスト) ↗ |
| Annals of the rheumatic diseases | 2024 | 20.6 | 2024年JIF公表概要(提供リスト) ↗ |
| Antioxidants (Basel, Switzerland) | 2024 | 6.6 | 2024年JIF公表概要(提供リスト) ↗ |
| Apoptosis : an international journal on programmed cell death | 2024 | 8.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Arthritis & Rheumatology | 2025 | 9.9 | ジャーナル/出版組織 ↗ |
| BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024 | 6.9 | 2024年JIF公表概要(提供リスト) ↗ |
| Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024 | 7.5 | 2024年JIF公表概要(提供リスト) ↗ |
| BMC Medicine | 2025 | 8.7 | ジャーナル/出版組織 ↗ |
| Brain, behavior, and immunity | 2024 | 7.6 | 2024年JIF公表概要(提供リスト) ↗ |
| CHEST | 2025 | 10.2 | ジャーナル/出版組織 ↗ |
| Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024 | 5.2 | 2024年JIF公表概要(提供リスト) ↗ |
| Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024 | 12.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024 | 7.3 | 2024年JIF公表概要(提供リスト) ↗ |
| Clinical journal of the American Society of Nephrology : CJASN | 2024 | 7.1 | 2024年JIF公表概要(提供リスト) ↗ |
| CNS drugs | 2024 | 7.4 | 2024年JIF公表概要(提供リスト) ↗ |
| Critical care (London, England) | 2024 | 9.3 | 2024年JIF公表概要(提供リスト) ↗ |
| Diabetes care | 2024 | 16.6 | 2024年JIF公表概要(提供リスト) ↗ |
| Diabetes research and clinical practice | 2024 | 7.4 | 2024年JIF公表概要(提供リスト) ↗ |
| Diabetes, obesity & metabolism | 2024 | 5.7 | 2024年JIF公表概要(提供リスト) ↗ |
| Diabetes/metabolism research and reviews | 2024 | 6.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Drug Design, Development and Therapy | 2025 | 6.1 | ジャーナル/出版組織 ↗ |
| Drugs | 2024 | 14.4 | 2024年JIF公表概要(提供リスト) ↗ |
| EClinicalMedicine | 2024 | 10.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Endocrine Practice | 2025 | 4.4 | ジャーナル/出版組織 ↗ |
| Epilepsia | 2024 | 6.6 | 2024年JIF公表概要(提供リスト) ↗ |
| European heart journal | 2024 | 35.6 | 2024年JIF公表概要(提供リスト) ↗ |
| European heart journal. Cardiovascular pharmacotherapy | 2024 | 6.1 | 2024年JIF公表概要(提供リスト) ↗ |
| European journal of epidemiology | 2024 | 5.9 | 2024年JIF公表概要(提供リスト) ↗ |
| European journal of internal medicine | 2024 | 6.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Frontiers in immunology | 2024 | 5.9 | 2024年JIF公表概要(提供リスト) ↗ |
| Gastroenterology | 2024 | 25.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Gut | 2024 | 25.8 | 2024年JIF公表概要(提供リスト) ↗ |
| Hepatology international | 2024 | 6.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Inflammation research : official journal of the European Histamine Research Society ... [et al.] | 2024 | 5.4 | 2024年JIF公表概要(提供リスト) ↗ |
| International journal of biological sciences | 2024 | 10.0 | 2024年JIF公表概要(提供リスト) ↗ |
| International journal of epidemiology | 2024 | 5.9 | 2024年JIF公表概要(提供リスト) ↗ |
| JAMA | 2024 | 55.0 | 2024年JIF公表概要(提供リスト) ↗ |
| JAMA internal medicine | 2024 | 23.3 | 2024年JIF公表概要(提供リスト) ↗ |
| JAMA Network Open | 2025 | 11.7 | ジャーナル/出版組織 ↗ |
| JAMA ophthalmology | 2024 | 9.2 | 2024年JIF公表概要(提供リスト) ↗ |
| JAMA otolaryngology-- head & neck surgery | 2024 | 5.6 | 2024年JIF公表概要(提供リスト) ↗ |
| JAMA pediatrics | 2024 | 18.0 | 2024年JIF公表概要(提供リスト) ↗ |
| JMIR medical education | 2024 | 12.5 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of autoimmunity | 2024 | 7.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of clinical anesthesia | 2024 | 5.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024 | 41.9 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of internal medicine | 2024 | 9.2 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of the American Academy of Dermatology | 2024 | 11.8 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of the American Heart Association | 2025 | 6.0 | Bioxbio 年次情報 ↗ |
| Journal of the European Academy of Dermatology and Venereology : JEADV | 2024 | 8.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of the National Cancer Institute | 2024 | 7.2 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of the National Comprehensive Cancer Network : JNCCN | 2024 | 16.4 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of the Royal Society of Medicine | 2024 | 7.1 | 2024年JIF公表概要(提供リスト) ↗ |
| Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024 | 20.8 | 2024年JIF公表概要(提供リスト) ↗ |
| Kidney international reports | 2024 | 5.7 | 2024年JIF公表概要(提供リスト) ↗ |
| Lancet (London, England) | 2024 | 88.5 | 2024年JIF公表概要(提供リスト) ↗ |
| Mayo Clinic Proceedings | 2025 | 6.5 | ジャーナル/出版組織 ↗ |
| Metabolism: Clinical and Experimental | 2025 | 16.7 | ジャーナル/出版組織 ↗ |
| Molecular cancer | 2024 | 33.9 | 2024年JIF公表概要(提供リスト) ↗ |
| Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2024 | 5.6 | 2024年JIF公表概要(提供リスト) ↗ |
| NPJ vaccines | 2024 | 6.5 | 2024年JIF公表概要(提供リスト) ↗ |
| Nutrients | 2024 | 5.0 | 2024年JIF公表概要(提供リスト) ↗ |
| Ophthalmology | 2024 | 9.5 | 2024年JIF公表概要(提供リスト) ↗ |
| Osteoarthritis and Cartilage | 2025 | 9.2 | ジャーナル/出版組織 ↗ |
| Pharmacological research | 2024 | 10.5 | 2024年JIF公表概要(提供リスト) ↗ |
| QJM : monthly journal of the Association of Physicians | 2024 | 6.4 | 2024年JIF公表概要(提供リスト) ↗ |
| The American journal of gastroenterology | 2024 | 7.6 | 2024年JIF公表概要(提供リスト) ↗ |
| The American journal of medicine | 2024 | 5.3 | 2024年JIF公表概要(提供リスト) ↗ |
| The British journal of psychiatry : the journal of mental science | 2024 | 7.6 | 2024年JIF公表概要(提供リスト) ↗ |
| The European respiratory journal | 2024 | 21.0 | 2024年JIF公表概要(提供リスト) ↗ |
| The Journal of allergy and clinical immunology | 2024 | 11.2 | 2024年JIF公表概要(提供リスト) ↗ |
| The journal of allergy and clinical immunology. In practice | 2024 | 6.6 | 2024年JIF公表概要(提供リスト) ↗ |
| The Journal of clinical endocrinology and metabolism | 2024 | 5.1 | 2024年JIF公表概要(提供リスト) ↗ |
| The journal of prevention of Alzheimer's disease | 2024 | 7.8 | 2024年JIF公表概要(提供リスト) ↗ |
| The Lancet regional health. Western Pacific | 2024 | 8.1 | 2024年JIF公表概要(提供リスト) ↗ |
| The New England journal of medicine | 2024 | 78.5 | 2024年JIF公表概要(提供リスト) ↗ |
| Theranostics | 2024 | 13.3 | 2024年JIF公表概要(提供リスト) ↗ |
| Thorax | 2024 | 7.7 | 2024年JIF公表概要(提供リスト) ↗ |